Use of mesoporous polydopamine nanoparticles as a stable drug-release system alleviates inflammation in knee osteoarthritis

Osteoarthritis drugs are often short-acting; therefore, to enhance their efficacy, long-term, stable-release, drug-delivery systems are urgently needed. Mesoporous polydopamine (MPDA), a natural nanoparticle with excellent biocompatibility and a high loading capacity, synthesized via a self-aggregat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yun, Ge, Weiwen, Ma, Zhigui, Ji, Guangyu, Wang, Mingsong, Zhou, Guangdong, Wang, Xiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIP Publishing LLC 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033307/
https://www.ncbi.nlm.nih.gov/pubmed/35496642
http://dx.doi.org/10.1063/5.0088447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033307/
https://www.ncbi.nlm.nih.gov/pubmed/35496642
http://dx.doi.org/10.1063/5.0088447

Ejemplares similares